Home » FDA OKs Raltegravir for Kids, Teens With HIV
FDA OKs Raltegravir for Kids, Teens With HIV
The integrase inhibitor raltegravir (Isentress) can be used to treat HIV in children and adolescents ages 2 through 18, the FDA said.
MedPage Today
MedPage Today
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May